Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/16/2025

Neonatal Mortality

Introduction to Risk Factors

  • Hipoxemia is common among hospitalized neonates in low- and middle-income countries, affecting 24.5% of admitted neonates, according to the World Health Organization guidelines 1
  • The prevalence of obesity in pregnant women (36.9% of the adult female population) increases the risk of neonatal complications, as stated by the American College of Obstetricians and Gynecologists 2

Causes of Neonatal Mortality

  • The mortality rate is significantly higher in areas with lower economic development, as reported by the World Health Organization 1
  • Neonatal sepsis accounts for approximately 22% of global annual neonatal deaths, with Gram-negative bacteria causing about 60% of cases in low- and lower-middle-income countries (LLMICs) 3
  • The American Academy of Pediatrics recommends promoting breastfeeding, which reduces the risk of infant mortality by 19-21% 4

Interventions to Reduce Neonatal Mortality

  • Improving access to oxygen and respiratory care is fundamental for reducing mortality from respiratory distress syndrome (RDS), as recommended by the World Health Organization 1
  • The American College of Obstetricians and Gynecologists suggests that improving prenatal care, especially for women with risk factors such as obesity or gestational diabetes, can help reduce neonatal complications 2
  • The Centers for Disease Control and Prevention recommend implementing programs for antimicrobial administration to prevent neonatal sepsis and reduce antimicrobial resistance 1

Neonatal Sepsis

  • Neonatal sepsis is a major cause of mortality and morbidity worldwide, with mortality rates of 11-19% in high and middle-income countries, and significantly higher rates in LLMICs where the incidence can be up to 40 times higher than in high-income countries 3
  • Neonatal sepsis is typically classified based on timing of onset, with early-onset sepsis (EOS) occurring within 72 hours to 7 days of birth and late-onset sepsis (LOS) occurring after 72 hours or 7 days up to 28 days of life 3
  • Common causes of EOS include Group B Streptococcus, while Klebsiella species and Escherichia coli are common causes of Gram-negative sepsis 3, 5
  • Maternal risk factors for neonatal sepsis include GBS colonization, prolonged rupture of membranes, maternal fever or chorioamnionitis, and urinary tract infection during pregnancy 5
  • Neonatal risk factors include prematurity, low birth weight, male gender, invasive procedures, prolonged hospital stay, and central venous catheters 3

Diagnosis and Management of Neonatal Sepsis

  • Recognition of decreased mental status and perfusion, with initiation of high-flow oxygen and establishment of IV/IO access, is crucial in the management of neonatal sepsis 6
  • Fluid resuscitation with isotonic saline or colloid, correction of hypoglycemia and hypocalcemia, and empiric antibiotic therapy are essential components of treatment 6
  • Inotropes and vasopressors may be necessary for fluid-refractory shock, with consideration of hydrocortisone therapy for adrenal insufficiency 6
  • The American Academy of Pediatrics (AAP) recommends reevaluation of antibiotic therapy when culture results are available to prevent prolonged empiric antibiotic therapy and reduce antimicrobial resistance 3

Antimicrobial Resistance and Stewardship

  • Significant resistance to WHO-recommended first-line antimicrobials has been documented, including ampicillin resistance in 90% of E. coli cases and carbapenem resistance in 10% of E. coli and Klebsiella cases 3
  • Empiric antibiotic selection should be guided by regional antimicrobial resistance patterns, with consideration of intrapartum antibiotic prophylaxis for GBS-positive mothers and strict infection control measures in neonatal units 3
  • Antimicrobial stewardship programs are essential for preventing neonatal sepsis and reducing antimicrobial resistance 3

Outcomes and Challenges

  • Early diagnosis and prompt intervention with aggressive fluid therapy and antibiotics significantly improve outcomes in neonatal sepsis 7
  • Attainment of cardiac index 3.3-6.0 L/min/m² and oxygen consumption >200 mL/min/m² is associated with improved survival 6
  • Outcomes are significantly worse in LLMICs due to higher antimicrobial resistance rates and limited resources 3
  • Diagnostic challenges include the lack of optimal diagnostic tests and frequent presence of noninfectious conditions that resemble sepsis 3
  • Treatment dilemmas include balancing the risks of antibiotic overuse with the need for prompt treatment, with consideration of alternative therapies and prevention strategies 3